フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma...
Hikma Pharmaceuticals Plc 19 March 2025 Hikma Pharmaceuticals PLC 2024 Annual Report and Accounts and Notice of 2025 Annual General Meeting ...
Hikma Pharmaceuticals Plc 04 March 2025 Hikma Pharmaceuticals PLC - EIP Vesting LONDON, 4 March 2025: Hikma Pharmaceuticals PLC (LSE: HIK...
Hikma Pharmaceuticals PLC on Wednesday said it planned to increased spending on research and development to support f ...
Hikma Pharmaceuticals Plc 26 February 2025 Strong 2024 performance and a positive outlook for 2025 London, 26 February 2025 - Hikma...
Hikma Pharmaceuticals PLC is set to report healthy annual revenue and core operating profit growth, albeit at a slowe ...
Hikma Pharmaceuticals Plc 10 February 2025 London, 10 February 2025 - Hikma Pharmaceuticals PLC (Hikma, Group), will announce its financial...
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal...
Hikma Pharmaceuticals Plc 23 December 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 23 December 2024: Hikma Pharmaceuticals PLC (LSE:...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma Pharmaceuticals PLC Outcome of Audit Tender Process LONDON, 7 November 2024 - Hikma...
Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading t ...
Hikma Pharmaceuticals Plc 07 November 2024 Hikma continues strong strategic execution and reiterates guidance London, 7 November 2024...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す